Impact of Oxaliplatin-based chemotherapy on the haemoglobin levels: A retrospective analysis in patients with colorectal cancer

被引：0
|
作者：
Queralt, Bernardo [1 ]
Juez, Ignacio [1 ]
Hernandez, Xavier [1 ]
Vinas, Gemma [1 ]
Rubio, Jordi [1 ]
Soler, Francesc [1 ]
Monleon, Antonio [2 ]
Colomer, Ramon [1 ]
机构：
[1] Hosp Josep Trueta, Inst Catala Oncol, Dept Oncol, Girona, Spain
[2] Univ Barcelona, Dept Stat, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric Cancer
    Inadomi, Kyoko
    Kusaba, Hitoshi
    Matsushita, Yuzo
    Tanaka, Risa
    Mitsugi, Kenji
    Arimizu, Kohei
    Hirano, Gen
    Makiyama, Akitaka
    Ohmura, Hirofumi
    Uchino, Keita
    Hanamura, Fumiyasu
    Shibata, Yoshihiro
    Kuwayama, Miyuki
    Esaki, Taito
    Takayoshi, Kotoe
    Arita, Shuji
    Ariyama, Hiroshi
    Akashi, Koichi
    Baba, Eishi
    ANTICANCER RESEARCH, 2017, 37 (05) : 2663 - 2671
  • [42] PKM2 Expression as Biomarker for Resistance to Oxaliplatin-Based Chemotherapy in Colorectal Cancer
    Sfakianaki, Maria
    Papadaki, Chara
    Tzardi, Maria
    Trypaki, Maria
    Manolakou, Stavroula
    Messaritakis, Ippokratis
    Saridaki, Zenia
    Athanasakis, Elias
    Mavroudis, Dimitrios
    Tsiaoussis, John
    Gouvas, Nikolaos
    Souglakos, John
    CANCERS, 2020, 12 (08) : 1 - 14
  • [43] PKM2 expression as biomarker for resistance to oxaliplatin-based chemotherapy in colorectal cancer
    Sfakianaki, M.
    Papadaki, C.
    Tzardi, M.
    Trypaki, M.
    Manolakou, S.
    Messaritakis, I.
    Saridaki, Z.
    Mavroudis, D.
    Georgoulias, V.
    Souglakos, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [44] Analysis of oxaliplatin-based chemotherapy induced liver injury in patients with advanced colorectal cancer with special references to von Willebrand factor
    Nishigori, N.
    Matsumoto, M.
    Koyama, F.
    Hayakawa, M.
    Hatakeyama, K.
    Fujimura, Y.
    Nakajima, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 751 - 752
  • [45] IMPACT OF KRAS MUTATION & ERCC1 OVER-EXPRESSION ON OXALIPLATIN-BASED CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER PATIENTS.
    Park, S.
    Lee, I.
    DISEASES OF THE COLON & RECTUM, 2017, 60 (06) : E342 - E342
  • [46] Impact of pelvis irradiation on toxicity of further oxaliplatin-based chemotherapy in rectal cancer
    Spalek, M.
    Michalski, W.
    Bujko, K.
    Wyrwicz, L.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S797 - S797
  • [47] Splenomegaly during oxaliplatin-based chemotherapy in colon cancer
    Ji, Ruoyu
    Huang, Guanghua
    Liu, Lingshan
    Chen, Mengyin
    Yu, Xiaoduo
    Zhou, Aiping
    Du, Chun-Xia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [48] Definition of oxaliplatin sensitivity in patients with advanced colorectal cancer previously treated with oxaliplatin-based therapy
    de Gramont Lesparre, A. H.
    Chibaudel, B.
    Bourges, O.
    Perez-Staub, N.
    Tournigand, C.
    Maindrault-Goebel, F.
    Andre, T.
    Larsen, A. K.
    Afchain, P.
    Louvet, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    L Paré-Brunet
    A Sebio
    J Salazar
    A Berenguer-Llergo
    E Río
    A Barnadas
    M Baiget
    D Páez
    The Pharmacogenomics Journal, 2015, 15 : 397 - 404
  • [50] Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    Pare-Brunet, L.
    Sebio, A.
    Salazar, J.
    Berenguer-Llergo, A.
    Rio, E.
    Barnadas, A.
    Baiget, M.
    Paez, D.
    PHARMACOGENOMICS JOURNAL, 2015, 15 (05): : 397 - 404
12345